diabetic retinopathy glp 1 GLP-1 Drugs and Ocular Disease: Between Neuroprotection and Risk The Effect of Glucagon-Like Peptide-1

10.1056/NEJMc1615712 55 McDonaghT

The complex interaction of factors such as insulin resistance, glucotoxicity and lipotoxicity contribute to the pathogenesis and coexistence of diabetes and metabolic-dysfunction associated steatotic liver disease (MASLD) in a reciprocal process of exacerbating the underlying conditions [9]

Small molecules like orforglipron are produced through standard organic chemistry processes that pharmaceutical companies have scaled efficiently for decades

By combining cutting-edge GLP-1 medications with a personalized, empathetic touch, Rosaly Stephens, ARNP-C helps you overcome the biological hurdles of weight loss, allowing you to achieve sustainable results and a healthier lifestyle